Acta Biomaterialia · 2018 · 72 citations · 54 references
PharmacyMolecular PharmaceuticsOncologyDrug DeliveryMolecular OncologyNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignDrug Delivery NanocarriersErlotinib TherapyMultifunctional NanoparticlesNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentTumor Vascular NormalizationTumor Vasculature NormalizationTumor-targeted Drug Delivery
54
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
D Li, Lauren Ambrogio, Takeshi Shimamura et al. · Oncogene · 2008 · 1.4K citations · Full text
Medicine, Oncology, Pharmacology +11
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera‐Troise, Christopher Daly, Nicholas Papadopoulos et al. · Nature · 2006 · 1K citations
Medicine, Cancer Biology, Oncology +14
A PEGylated dendritic nanoparticulate carrier of fluorouracil
D. Bhadra, Sulekha Bhadra, Sanjay Jain et al. · International Journal of Pharmaceutics · 2003 · 542 citations